Antibiotic resistance: Nigeria stares at a major catastrophe
Sadiq Abdullahi sells medicine at Kpana Market in Utako district of Nigeria’s capital Abuja. In his 30s, he has been selling drugs in that open space for more than three years; his ware include different brands of antibiotics such as amoxicillin, ciprofloxacin, metronidazole, penicillin and clindamycin.
Sadiq charges less than registered pharmacies: A card of amoxicillin goes for 150 Nigerian naira — less than $0.40 cents — while a registered pharmaceutical store would charge more than $1. The most striking thing: He never asks for a prescription and is willing to sell even two tablets, disregarding treatment guidelines.
Sadiq sources his drugs from sellers from areas like Suleja and Mararaba on the outskirts of Abuja. They claim to be agents of manufacturers.
These drugs do not have the National Agency for Food and Drug Administration and Control’s authentication codes for verification. Among his clients is Jumai Abdullahi, who wanted to buy ciprofloxacin because she believed she was suffering from typhoid. The vendor agreed to her diagnosis, saying that the weakness of joints and headache she complains of are common symptoms of typhoid.
Boosting innovation in AMR?
15 OCT 2020: online Kick Off event AMR Innovation Mission UK 2021
The AMR Innovation Mission UK 2020/2021 aims to add to the global curbing of AMR by boosting joint early & translational research, R&D, clinical development, validation, registration and commercialisation of vaccines, microbial diagnostics and antimicrobial products.